Active	Status	Sponsor type	Region	Phase	Filter
4 Active 4 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Weiss, Michael
NCT02621944: Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia	Recruiting	1	70	US	Melatonin, Magnetic Resonance Imaging, MRI, Pharmacokinetics, Neurological Outcome Assessment	University of Florida, Thrasher Research Fund	Hypoxic Ischemic Encephalopathy	03/26	03/26
CNMAu8.EAP02, NCT05281484: Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and for ALS	Available	N/A		US	CNM-Au8, Nanocrystalline gold	Clene Nanomedicine	Amyotrophic Lateral Sclerosis
NCT02260271: Florida Neonatal Neurologic Network	Enrolling by invitation	N/A	1000	US	Database Entry/Biospecimen Collection	University of Florida	Hypoxic-Ischemic Encephalopathy	12/25	12/25
TALS LB, NCT05137665: Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures	Recruiting	N/A	1000	US, RoW		Target ALS Foundation, Inc.	Amyotrophic Lateral Sclerosis, Movement Disorders, Degenerative Disorder, Motor Neuron Disease	12/31	12/31